The latest antibiotic therapies and guidelines offer effective strategies for managing carbapenem-resistant Acinetobacter baumannii infections
Robert Dutcher, PharmD
Advertisement
Articles by Robert Dutcher, PharmD
Infectious Disease Society of America guidance defines difficult-to-treat resistant Pseudomonas aeruginosa as resistance to all first-line agents.
Dr. Dutcher is a registered pharmacist based in Punta Gorda, Fla.
Advertisement
Latest Updated Articles
- Guidelines Recommend ACE Inhibitor or ARB for Heart Failure
October 1st 2007
- When the Patient Won't Take the Medicine
February 1st 2007
- Medication Reconciliation Is Key
December 1st 2006
Advertisement
Advertisement
Trending on Pharmacy Times
1
Closing the Kidney Gap in Cardio-Kidney-Metabolic Care
2
FDA Approves At-Home Starting Dose of Lecanemab for Treatment of Alzheimer Disease
3
Pharmacists Can Catch Missed CKD With One Question
4
AI and Drug Information: Where OpenEvidence Stands Out—and Where Pharmacists Still Win
5